HUP0300125A2 - Propofolt tartalmazó érzéstelenítő készítmények - Google Patents

Propofolt tartalmazó érzéstelenítő készítmények

Info

Publication number
HUP0300125A2
HUP0300125A2 HU0300125A HUP0300125A HUP0300125A2 HU P0300125 A2 HUP0300125 A2 HU P0300125A2 HU 0300125 A HU0300125 A HU 0300125A HU P0300125 A HUP0300125 A HU P0300125A HU P0300125 A2 HUP0300125 A2 HU P0300125A2
Authority
HU
Hungary
Prior art keywords
propofol
formulations containing
containing propofol
poloxamer
anaesthetic formulations
Prior art date
Application number
HU0300125A
Other languages
English (en)
Inventor
James David Du Mayne
John Meadows
Original Assignee
Maelor Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maelor Pharmaceuticals Ltd. filed Critical Maelor Pharmaceuticals Ltd.
Publication of HUP0300125A2 publication Critical patent/HUP0300125A2/hu
Publication of HUP0300125A3 publication Critical patent/HUP0300125A3/hu
Publication of HU226485B1 publication Critical patent/HU226485B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgya Propofolt tartalmazó vizes, micellás poloxamerkészítmény, amelyben a poloxamer előnyösen P234, P237, P338 vagy P407kódszámú termék. A találmány tárgya továbbá a Propofol vizeskészítménye, amelyben a Propofol poloxamerek szinergetikus elegyébenvan szolubilizálva. Utóbbi készítményben előnyösen a szinergetikuspoloxamer elegy: P407 és P338, P234, P237, P188 vagy P108; P338 ésP234, P237, P188 vagy P108; P234 és P118 vagy P108; vagy P237 és P188vagy P108. Ó
HU0300125A 2000-02-29 2001-02-28 Anaesthetic formulations containing propofol HU226485B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0004841A GB2359747B (en) 2000-02-29 2000-02-29 Anaesthetic formulations
PCT/GB2001/000868 WO2001064187A2 (en) 2000-02-29 2001-02-28 Anaesthetic formulations

Publications (3)

Publication Number Publication Date
HUP0300125A2 true HUP0300125A2 (hu) 2003-07-28
HUP0300125A3 HUP0300125A3 (en) 2003-09-29
HU226485B1 HU226485B1 (en) 2009-03-02

Family

ID=9886669

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300125A HU226485B1 (en) 2000-02-29 2001-02-28 Anaesthetic formulations containing propofol

Country Status (21)

Country Link
US (2) US7166303B2 (hu)
EP (1) EP1259226B1 (hu)
JP (1) JP4215430B2 (hu)
KR (1) KR100652552B1 (hu)
CN (1) CN100376232C (hu)
AT (1) ATE324101T1 (hu)
AU (2) AU3580901A (hu)
BR (1) BR0108738A (hu)
CA (1) CA2401089C (hu)
CZ (1) CZ300790B6 (hu)
DE (1) DE60119082T2 (hu)
DK (1) DK1259226T3 (hu)
ES (1) ES2262628T3 (hu)
GB (1) GB2359747B (hu)
HU (1) HU226485B1 (hu)
IL (2) IL151311A0 (hu)
NO (1) NO20024095L (hu)
NZ (1) NZ520765A (hu)
RU (1) RU2250101C2 (hu)
WO (1) WO2001064187A2 (hu)
ZA (1) ZA200206233B (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1149984C (zh) * 1999-06-21 2004-05-19 健一制药株式会社 用于静脉注射的含有普鲁泊福的麻醉组合物
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations
US6939564B2 (en) 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
GB0120701D0 (en) * 2001-08-24 2001-10-17 Maelor Pharmaceuticals Ltd Pharmaceutical formulations
GB0120702D0 (en) * 2001-08-24 2001-10-17 Maelor Pharmaceuticals Ltd Anaesthetic formulations
GB0124071D0 (en) * 2001-10-08 2001-11-28 Kbig Ltd Improvement in the administration of high boiling point aneasthetics
EP1492544A4 (en) * 2002-04-08 2005-10-12 Guilford Pharm Inc PHARMACEUTICAL COMPOSITIONS CONTAINING PROPOFOL-BASED WATER-SOLUBLE PRODRUGS AND METHODS OF ADMINISTRATION THEREOF
NZ538255A (en) 2002-07-29 2006-11-30 Transform Pharmaceuticals Inc Aqueous 2,6-diisopropylphenol pharmaceutical compositions
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
GB0327390D0 (en) * 2003-11-25 2003-12-31 Pfizer Ltd Pharmaceutical formulations
AU2005215517C1 (en) * 2004-02-13 2011-04-14 Bioavailability, Inc. A microemulsion preparation of high concentration propofol for anesthetic uses
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
DE602005011500D1 (de) * 2005-07-08 2009-01-15 Physica Pharma Klare pharmazeutische wässrige mikroemulsion mit propofol und herstellungsverfahren
WO2007108505A1 (ja) * 2006-03-22 2007-09-27 Chugai Seiyaku Kabushiki Kaisha エリスロポエチン溶液製剤
CN100579510C (zh) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 新型前体胶束制剂及其生产方法
JP2010504318A (ja) * 2006-09-22 2010-02-12 ラボファーム インコーポレイテッド ｐＨ標的化薬剤送達のための組成物及び方法
KR20080102010A (ko) * 2007-05-17 2008-11-24 대원제약주식회사 프로포폴을 포함하는 주사제용 조성물 및 이의 제조 방법
WO2010088924A1 (en) * 2009-02-06 2010-08-12 Telormedix Sa Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
WO2012151544A1 (en) * 2011-05-05 2012-11-08 Wisconsin Alumni Research Foundation Micelles for the solubilization of gossypol
RU2535001C1 (ru) * 2013-07-11 2014-12-10 Общество с ограниченной ответственностью "ВИК-здоровье животных" Микроколлоидный раствор пропофола для анестезии
JP6235755B2 (ja) 2014-07-02 2017-11-22 ザ リサーチ ファウンデイション フォー ザ ステイト ユニバーシティー オブ ニューヨーク 高いカーゴ対サーファクタント比を有するサーファクタント除去ミセル組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
DE4039602A1 (de) * 1990-12-12 1992-06-17 Bauer Kurt Heinz Prof Dr Pharmazeutische formulierungen
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
GB9405593D0 (en) 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US5635536A (en) * 1994-12-07 1997-06-03 Pharmacia & Upjohn Aktiebolag Emulsion suitable for administering a sphingolipid
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
DE69912441T2 (de) * 1998-08-19 2004-08-19 Skyepharma Canada Inc., Verdun Injizierbare wässerige propofoldispersionen
CN1149984C (zh) * 1999-06-21 2004-05-19 健一制药株式会社 用于静脉注射的含有普鲁泊福的麻醉组合物
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
GB2359747B (en) * 2000-02-29 2002-04-24 Maelor Pharmaceuticals Ltd Anaesthetic formulations

Also Published As

Publication number Publication date
CN1416337A (zh) 2003-05-07
BR0108738A (pt) 2002-12-17
US20030138489A1 (en) 2003-07-24
RU2250101C2 (ru) 2005-04-20
HU226485B1 (en) 2009-03-02
GB2359747A (en) 2001-09-05
KR100652552B1 (ko) 2006-11-30
NZ520765A (en) 2003-07-25
WO2001064187B1 (en) 2002-03-07
IL151311A (en) 2007-10-31
US20070122467A1 (en) 2007-05-31
JP2003525231A (ja) 2003-08-26
CA2401089A1 (en) 2001-09-07
DK1259226T3 (da) 2006-08-21
ES2262628T3 (es) 2006-12-01
GB2359747B (en) 2002-04-24
GB0004841D0 (en) 2000-04-19
DE60119082D1 (de) 2006-06-01
IL151311A0 (en) 2003-04-10
JP4215430B2 (ja) 2009-01-28
CN100376232C (zh) 2008-03-26
ZA200206233B (en) 2003-11-05
AU3580901A (en) 2001-09-12
CZ300790B6 (cs) 2009-08-12
RU2002123180A (ru) 2004-03-20
WO2001064187A3 (en) 2002-01-03
ATE324101T1 (de) 2006-05-15
CZ20022914A3 (cs) 2003-01-15
US7166303B2 (en) 2007-01-23
EP1259226A2 (en) 2002-11-27
EP1259226B1 (en) 2006-04-26
CA2401089C (en) 2011-01-18
NO20024095L (no) 2002-10-23
WO2001064187A8 (en) 2002-10-03
KR20030011781A (ko) 2003-02-11
NO20024095D0 (no) 2002-08-28
AU2001235809B2 (en) 2004-08-05
HUP0300125A3 (en) 2003-09-29
WO2001064187A2 (en) 2001-09-07
DE60119082T2 (de) 2006-11-30

Similar Documents

Publication Publication Date Title
HUP0300125A2 (hu) Propofolt tartalmazó érzéstelenítő készítmények
CY1109212T1 (el) Φαρμακευτικες συνθεσεις για την θεραπεια του ασθμα
HK1107008A1 (en) Pharmaceutical formulations containing flavouring substances with improved pharmaceutical properties
RS20050066A (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
ATE533472T1 (de) Flüssige cannabinoid-formulierungen zur verabreichung an die schleimhäute
NO20041270D0 (no) Farmasoytiske sammensetninger som innbefatter kolloidal silikondioksid
BRPI0414428A (pt) composições farmacêuticas
CY1107992T1 (el) Συνθεσεις πολυαμιδο-αμικου οξεος υδατικης βασεως
WO2006081363A3 (en) Oral formulations for delivery of catecholic butanes including ndga compounds
DE60104206D1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
SE0201544D0 (sv) Novel compounds and thier use
HK1028879A1 (en) Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation
IL161500A0 (en) Taste masking spill-resistant formulation
PL347498A1 (en) Agent for repelling and inactivating pathogenic organisms of plants
CY1105934T1 (el) Φαρμακευτικη συνθεση που αποτελειται απο αναστολεα πενινης μη πεπτιδιου και επιφανειοδραστικο παραγοντα
IT1320080B1 (it) Composizione per uso farmaceutico o dietetico.
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
EA200400628A1 (ru) Таблетки метформина с контролируемым высвобождением активного компонента
WO2002062304A3 (de) Kosmetische und/oder pharmazeutische mittel acylierte aminosäure und proteinkondensat enthaltend.
MY134019A (en) Aryl oxime-piperazines useful as ccr5 antagonists
RS36504A (en) Linear basic compounds having nk-2 antagonist activity and formulations thereof
WO2004110373A3 (en) Therapeutic vaccine compositions for the treatment of type 1 diabetes
BR0210539A (pt) Processos de seleção e uso de vacinas de vetor antiartrópode
WO2002096546A8 (de) Tensidgemisch
DE60214476D1 (de) Pharmazeutische Zubereitungen, Wirkstoffe enthaltend, die sich für unerlaubte Verabreichung anbieten

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees